Molecular mechanisms of the effects of low concentrations of taxol in anaplastic thyroid cancer cells

Endocrinology

Volumn 145, Issue 7, 2004, Pages 3143-3152

  Pushkarev, V M ^a,b   Starenki, D V ^a   Saenko, V A ^a   Namba, H ^a   Kurebayashi, J ^c   Tronko, M D ^b   Yamashita, S ^a,d  

^a NAGASAKI UNIVERSITY   (Japan)

^b STATE INSTITUTION NATIONAL RESEARCH CENTER FOR RADIATION MEDICINE OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE   (Ukraine)

^c KAWASAKI MEDICAL SCHOOL   (Japan)

^d NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ANTINEOPLASTIC AGENT; CASPASE; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PACLITAXEL; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; RAF PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SURVIVIN; X LINKED INHIBITOR OF APOPTOSIS;

ANAPLASTIC CARCINOMA; APOPTOSIS; ARTICLE; CELL DEATH; CELL LINE; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG SENSITIVITY; ENZYME DEGRADATION; HUMAN; HUMAN CELL; LOW DRUG DOSE; MITOCHONDRION; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; THYROID CANCER; THYROID CELL; THYROID FOLLICULAR CARCINOMA;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENOCARCINOMA, FOLLICULAR; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BCL-2-ASSOCIATED X PROTEIN; CELL DEATH; CELL DIVISION; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM PROTEINS; PACLITAXEL; PHOSPHORYLATION; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; THYROID NEOPLASMS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 3042645219     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-0127     Document Type: Article

References (55)

1. Rowinsky EK 1997 The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Annu Rev Med 48:353-374
2. Ain KB, Tofiq S, Taylor KD 1996 Antineoplastic activity of Taxol against human anaplastic thyroid carcinoma cell lines in vitro and in vivo. J Clin Endocrinol Metab 81:3650-3653
3. Ain KB, Egorin MJ, DeSimone PA 2000 Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group. Thyroid 10:587-594
4. Yeung SC, Xu G, Pan J, Christgen M, Bamiagis A 2000 Manumycin enhances the cytotoxic effect of paclitaxel on anaplastic thyroid carcinoma cells. Cancer Res 60:650-656
5. Clark OH 1996 Predictors of thyroid tumor aggressiveness. West J Med 165:131-138
6. Au JL, Kumar RR, Li D, Wientjes MG 1999 Kinetics of hallmark biochemical changes in paclitaxel-induced apoptosis. AAPS PharmSci 1:E8
7. Torres K, Horwitz SB 1998 Mechanisms of Taxol-induced cell death are concentration dependent. Cancer Res 58:3620-3626
8. Wang TH, Wang HS, Soong YK 2000 Paclitaxel-induced cell death: where the cell cycle and apoptosis come together. Cancer 88:2619-2628
9. Shiah SG, Chuang SE, Kuo ML 2001 Involvement of Asp-Glu-Val-Asp-directed, caspase-mediated mitogen-activated protein kinase kinase 1 cleavage, c-Jun N-terminal kinase activation, and subsequent Bcl-2 phosphorylation for paclitaxel-induced apoptosis in HL-60 cells. Mol Pharmacol 59:254-262
10. Boldt S, Weidle UH, Kolch W 2002 The role of MAPK pathways in the action of chemotherapeutic drugs. Carcinogenesis 23:1831-1838
11. Bacus SS, Gudkov AV, Lowe M, Lyass L, Yung Y, Komarov AP, Keyomarsi K, Yarden Y, Seger R 2001 Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. Oncogene 20:147-155
12. Deacon K, Mistry P, Chernoff J, Blank JL, Patel R 2003 p38 Mitogen-activated protein kinase mediates cell death and p21-activated kinase mediates cell survival during chemotherapeutic drug-induced mitotic arrest. Mol Biol Cell 14:2071-2087
13. Blagosklonny MV, Chuman Y, Bergan RC, Fojo T 1999 Mitogen-activated protein kinase pathway is dispensable for microtubule-active drug-induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemia cells. Leukemia 13:1028-1036
14. Okano J, Rustgi AK 2001 Paclitaxel induces prolonged activation of the Ras/MEK/ERK pathway independently of activating the programmed cell death machinery. J Biol Chem 276:19555-19564
15. Zhang H, Morisaki T, Nakahara C, Matsunaga H, Sato N, Nagumo F, Tadano J, Katano M 2003 PSK-mediated NF-κB inhibition augments docetaxel-induced apoptosis in human pancreatic cancer cells NOR-P1. Oncogene 22:2088-2096
16. Kawabe Y, Eguchi K, Shimomura C, Mine M, Otsubo T, Ueki Y, Tezuka H, Nakao H, Kawakami A, Migita K 1989 Interleukin-1 production and action in thyroid tissue. J Clin Endocrinol Metab 68:1174-1183
17. Freshney RI 2000 Culture of animal cells: a manual of basic techniques. 4th ed. New York: Wiley-Liss
18. Scaduto Jr RC, Grotyohann LW 1999 Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives. Biophys J 76:469-477
19. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM 1995 Yama/CPP32 β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly-(ADP-ribose) polymerase. Cell 81:801-809
20. Thorbum A 2004 Death receptor-induced cell killing. Cell Signal 16:139-144
21. Leist M, Jaattela M 2001 Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2:589-598
22. Liston P, Fong WG, Korneluk RG 2003 The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene 22:8568-8580
23. West KA, Castillo SS, Dennis PA 2002 Activation of the PI3K/Akt pathway and chemotherapeutic resistance. Drug Resist Updat 5:234-248
24. Jordan MA, Toso RJ, Thrower D, Wilson L 1993 Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci USA 90:9552-9556
25. Jordan MA, Wendell K, Gardiner S, Deny WB, Copp H, Wilson L 1996 Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res 56:816-825
26. Giannakakou P, Nakano M, Nicolaou KC, O'Brate A, Yu J, Blagosklonny MV, Greber UF, Fojo T 2002 Enhanced microtubule-dependent trafficking and p53 nuclear accumulation by suppression of microtubule dynamics. Proc Natl Acad Sci USA 99:10855-10860
27. Carre M, Andre N, Carles G, Borghi H, Brichese L, Briand C, Braguer D 2002 Tubulin is an inherent component of mitochondrial membranes that interacts with the voltage-dependent anion channel. J Biol Chem 277:33664-33669
28. Ferlini C, Raspaglio G, Mozzetti S, Distefano M, Filippetti F, Martinelli E, Ferrandina G, Gallo D, Ranelletti FO, Scambia G 2003 Bcl-2 down-regulation is a novel mechanism of paclitaxel resistance. Mol Pharmacol 64:51-58
29. Kidd JF, Pilkington MF, Schell MJ, Fogarty KE, Skepper JN, Taylor CW, Thorn P 2002 Paclitaxel affects cytosolic calcium signals by opening the mitochondrial permeability transition pore. J Biol Chem 277:6504-6510
30. Andre N, Carre M, Brasseur G, Pourroy B, Kovacic H, Briand C, Braguer D 2002 Paclitaxel targets mitochondria upstream of caspase activation in intact human neuroblastoma cells. FEBS Lett 532:256-260
31. Kottke TJ, Blajeski AL, Martins LM, Mesner Jr PW, Davidson NE, Earnshaw WC, Armstrong DK, Kaufmann SH 1999 Comparison of paclitaxel-, 5-fluoro2′-deoxyuridine-, and epidermal growth factor (EGF)-induced apoptosis. Evidence for EGF-induced anoikis. J Biol Chem 274:15927-15936
32. Yuan SY, Hsu SL, Tsai KJ, Yang CR 2002 Involvement of mitochondrial pathway in Taxol-induced apoptosis of human T24 bladder cancer cells. Urol Res 30:282-288
33. Gazitt Y, Rothenberg ML, Hilsenbeck SG, Fey V, Thomas C, Montegomrey W 1998 Bcl-2 overexpression is associated with resistance to paclitaxel, but not gemcitabine, in multiple myeloma cells. Int J Oncol 13:839-848
34. Nuydens R, Dispersyn G, Van Den Kieboom G, de Jong M, Connors R, Ramaekers F, Borgers M, Geerts H 2000 Bcl-2 protects neuronal cells against Taxol-induced apoptosis by inducing multi-nucleation. Apoptosis 5:335-343
35. Blagosklonny MV, Schulte T, Nguyen P, Trepel J, Neckers LM 1996 Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res 56:1851-1854
36. Basu A, Haldar S 1998 Microtubule-damaging drugs triggered bcl2 phosphorylation-requirement of phosphorylation on both serine-70 and serine-87 residues of bcl2 protein. Int J Oncol 13:659-664
37. Srivastava RK, Mi QS, Hardwick JM, Longo DL 1999 Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis. Proc Natl Acad Sci USA 96:3775-3780
38. Shitashige M, Toi M, Yano T, Shibata M, Matsuo Y, Shibasaki F 2001 Dissociation of Bax from a Bcl-2/Bax heterodimer triggered by phosphorylation of serine 70 of Bcl-2. J Biochem (Tokyo) 130:741-748
39. Nehme A, Varadarajan P, Sellakumar G, Gerhold M, Niedner H, Zhang Q, Lin X, Christen RD 2001 Modulation of docetaxel-induced apoptosis and cell cycle arrest by all-trans retinoic acid in prostate cancer cells. Br J Cancer 84:1571-1576
40. Scatena CD, Stewart ZA, Mays D, Tang LJ, Keefer CJ, Leach SD, Pietenpol JA 1998 Mitotic phosphorylation of Bcl-2 during normal cell cycle progression and Taxol-induced growth arrest. J Biol Chem 273:30777-30784
41. Brichese L, Barboule N, Heliez C, Valette A 2002 Bcl-2 phosphorylation and proteasome-dependent degradation induced by paclitaxel treatment: consequences on sensitivity of isolated mitochondria to Bid. Exp Cell Res 278:101-111
42. Lens SM, Wolthuis RM, Klompmaker R, Kauw J, Agami R, Brummelkamp T, Kops G, Medema RH 2003 Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension. EMBO J 22:2934-2947
43. Takahashi R, Deveraux Q, Tamm I, Welsh K, Assa-Munt N, Salvesen GS, Reed JC 1998 A single BIR domain of XIAP sufficient for inhibiting caspases. J Biol Chem 273:7787-7790
44. Stehlik C, de Martin R, Kumabashiri I, Schmid JA, Binder BR, Lipp J 1998 Nuclear factor (NF)-κB-regulated X-chromosome-linked IAP gene expression protects endothelial cells from tumor necrosis factor α-induced apoptosis. J Exp Med 188:211-216
45. Dong QG, Sclabas GM, Fujioka S, Schmidt C, Peng B, Wu T, Tsao MS, Evans DB, Abbruzzese JL, McDonnell TJ, Chiao PJ 2002 The function of multiple IκB : NF-κB complexes in the resistance of cancer cells to Taxol-induced apoptosis. Oncogene 21:6510-6519
46. Fahy BN, Schlieman M, Virudachalam S, Bold RJ 2003 AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2. Br J Cancer 89:391-397
47. Mollinedo F, Gajate C 2003 Microtubules, microrubule-interfering agents and apoptosis. Apoptosis 8:413-450
48. Basu A, You SA, Haldar S 2000 Regulation of Bcl2 phosphorylation by stress response kinase pathway. Int J Oncol 16:497-500
49. Namba H, Nakashima M, Hayashi T, Hayashida N, Maeda S, Rogounovitch TI, Ohtsuru A, Saenko VA, Kanematsu T, Yamashita S 2003 Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers. J Clin Endocrinol Metab 88:4393-4397
50. Hu Y, Bally M, Dragowska WH, Mayer L 2003 Inhibition of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase enhances chemotherapeutic effects on H460 human non-small cell lung cancer cells through activation of apoptosis. Mol Cancer Ther 2:641-649
51. Zelivianski S, Spellman M, Kellerman M, Kakitelashvilli V, Zhou XW, Lugo E, Lee MS, Taylor R, Davis TL, Hauke R, Lin MF 2003 ERK inhibitor PD98059 enhances docetaxel-induced apoptosis of androgen-independent human prostate cancer cells. Int J Cancer 107:478-485
52. Brazil DP, Hemmings BA 2001 Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem Sci 26:657-664
53. Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C 2003 PI3K/Akt and apoptosis: size matters. Oncogene 22:8983-8998
54. Sizemore N, Leung S, Stark GR 1999 Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-κB p65/RelA subunit. Mol Cell Biol 19:4798-4805
55. Gustafson DL, Long ME, Zirrolli JA, Duncan MW, Holden SN, Pierson AS, Eckhardt SG 2003 Analysis of docetaxel pharmacokinetics in humans with the inclusion of later sampling time-points afforded by the use of a sensitive tandem LCMS assay. Cancer Chemother Pharmacol 52:159-166